3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Evaluation of time to sputum smear conversion and its association with treatment outcomes among drug-resistant tuberculosis patients: a retrospective record-reviewing study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: This study examined the time to sputum smear and culture conversion and determinants of conversion, as well as variables associated with treatment outcomes among drug-resistant pulmonary tuberculosis (DR-PTB) cases.

          Methods: The electronic database and written medical records of patients were utilized to assess the sociodemographic, clinical, microbiological, and treatment characteristics and outcomes of study participants.

          Results: Among 736 patients with pulmonary tuberculosis (PTB), the mean age was 36.5 ± 16.5 years, with males comprising 53.4% and a mean weight of 47.76 ± 11.97 kg. The median time period for sputum smear conversion and sputum culture conversion was a month. The first-month culture conversion ( p < 0.001, aOR = 5.817, and 95% CI = 3.703–9.138) was the determinant of sputum smear conversion and receiver operating curve analysis with AUC = 0.881, 95% CI = 0.855–0.907, and p < 0.001, which showed a high level of predictive ability for the regression model for the initial sputum smear conversion. However, the first-month sputum conversion ( p < 0.001, aOR = 7.446, and 95% CI = 4.869–11.388) was attributed to sputum culture conversion, and the model has shown excellent predictive ability for regression with ROC curve analysis demonstrating AUC = 0.862, 95% CI = 0.835–0.889, and p < 0.001. A total of 63.2% of patients showed favorable treatment outcomes, with 63.1% of cases achieving treatment-cured status. The previous use of SLD, history of smoking, duration of illness ≤ 1 year, extensively drug-resistant tuberculosis, and first-month sputum conversion were the variables attributed to favorable treatment outcomes observed in drug-resistant pulmonary tuberculosis cases. ROC curve analysis with AUC = 0.902, 95% CI = 0.877–0.927, and p < 0.001) has shown outstanding ability for regression model prediction for the variables influencing treatment outcomes.

          Conclusions: Within 2 months of treatment, most patients had converted their sputum cultures and sputum smears. The determinants of early sputum smear and sputum culture conversion, as well as favorable treatment outcomes, were identified. These factors should be considered during the design and implementation of effective strategies for drug-resistant tuberculosis control programs.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: found

          The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB

          Objective To review the data presented in the 2021 WHO global TB report and discuss the current constraints in the global response. Introduction and methods The WHO global TB reports, consolidate TB data from countries and provide up to date assessment of the global TB epidemic. We reviewed the data presented in the 2021 report. Results We noted that the 2021 WHO global TB report presents a rather grim picture on the trajectory of the global epidemic of TB including a stagnation in the annual decline in TB incidence, a decline in TB notifications and an increase in estimated TB deaths. All the targets set at the 2018 United Nations High Level Meeting on TB were off track. Interpretation and conclusion The sub-optimal global performance on achieving TB control targets in 2020 is attributed to the on-going COVID-19 pandemic, however, TB programs were already off track well before the onset of the pandemic, suggesting that the pandemic amplified an already fragile global TB response. We emphasize that ending the global TB epidemic will require bold leadership, optimization of existing interventions, widespread coverage, addressing social determinants of TB and importantly mobilization of adequate funding required for TB care and prevention.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia

            Background Monitoring the outcome of tuberculosis treatment and understanding the specific reasons for unsuccessful treatment outcome are important in evaluating the effectiveness of tuberculosis control program. This study investigated tuberculosis treatment outcomes and predictors for unsuccessful treatment outcome in the Tigray region of Ethiopia. Methods Medical records of smear-positive pulmonary tuberculosis (PTB) patients registered from September 2009 to June 2011 in 15 districts of Tigray region, Northern Ethiopia, were reviewed. Additional data were collected using a structured questionnaire administered through house-to-house visits by trained nurses. Tuberculosis treatment outcomes were assessed according to WHO guidelines. The association of unsuccessful treatment outcome with socio-demographic and clinical factors was analyzed using logistic regression model. Results Out of the 407 PTB patients (221 males and 186 females) aged 15 years and above, 89.2% had successful and 10.8% had unsuccessful treatment outcome. In the final multivariate logistic model, the odds of unsuccessful treatment outcome was higher among patients older than 40 years of age (adj. OR = 2.50, 95% CI: 1.12-5.59), family size greater than 5 persons (adj. OR = 3.26, 95% CI: 1.43-7.44), unemployed (adj. OR = 3.10, 95% CI: 1.33-7.24) and among retreatment cases (adj. OR = 2.00, 95% CI: 1.37-2.92) as compared to their respective comparison groups. Conclusions Treatment outcome among smear-positive PTB patients was satisfactory in the Tigray region of Ethiopia. Nonetheless, those patients at high risk of an unfavorable treatment outcome should be identified early and given additional follow-up and social support.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis

              Objective To produce pooled estimates of the global results of tuberculosis (TB) treatment and analyze the predictive factors of successful TB treatment. Methods Studies published between 2014 and 2019 that reported the results of the treatment of pulmonary TB and the factors that influenced these results. The quality of the studies was evaluated according to the Newcastle-Ottawa quality assessment scale. A random effects model was used to calculate the pooled odds ratio (OR) and 95% confidence interval (CI). This review was registered in the International Prospective Register of Systematic Reviews (PROSPERO) in February 2019 under number CRD42019121512. Results A total of 151 studies met the criteria for inclusion in this review. The success rate for the treatment of drug-sensitive TB in adults was 80.1% (95% CI: 78.4–81.7). America had the lowest treatment success rate, 75.9% (95% CI: 73.8–77.9), and Oceania had the highest, 83.9% (95% CI: 75.2–91.0). In children, the success rate was 84.8% (95% CI: 77.7–90.7); in patients coinfected with HIV, it was 71.0% (95% CI: 63.7–77.8), in patients with multidrug-resistant TB, it was 58.4% (95% CI: 51.4–64.6), in patients with and extensively drug-resistant TB it was 27.1% (12.7–44.5). Patients with negative sputum smears two months after treatment were almost three times more likely to be successfully treated (OR 2.7; 1.5–4.8), whereas patients younger than 65 years (OR 2.0; 1.7–2.4), nondrinkers (OR 2.0; 1.6–2.4) and HIV-negative patients (OR 1.9; 1.6–2.5 3) were two times more likely to be successfully treated. Conclusion The success of TB treatment at the global level was good, but was still below the defined threshold of 85%. Factors such as age, sex, alcohol consumption, smoking, lack of sputum conversion at two months of treatment and HIV affected the success of TB treatment.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/1136482/overviewRole: Role: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2676541/overviewRole: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/141555/overviewRole: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/958889/overviewRole: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1637596/overviewRole: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1584888/overviewRole: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/1132841/overviewRole: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2012129/overviewRole:
                URI : https://loop.frontiersin.org/people/2098920/overviewRole: Role: Role:
                URI : https://loop.frontiersin.org/people/141557/overviewRole: Role: Role:
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                05 June 2024
                2024
                : 15
                : 1370344
                Affiliations
                [1] 1 Department of Clinical Pharmacy , College of Pharmacy , Jouf University , Sakaka, Saudi Arabia
                [2] 2 Institute of Pharmacy , Faculty of Pharmaceutical and Allied Health Sciences , Lahore College for Women University , Lahore, Pakistan
                [3] 3 Department of Clinical Pharmacy , College of Pharmacy , Taif University , Taif, Saudi Arabia
                [4] 4 Department of Clinical Pharmacy , College of Pharmacy , Prince Sattam Bin Abdulaziz University , Al-Kharj, Saudi Arabia
                [5] 5Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University , Sakaka, Saudi Arabia
                Author notes

                Edited by: Subash Babu, International Centers for Excellence in Research (ICER), India

                Reviewed by: Radha Gopalaswamy, National Institute of Research in Tuberculosis (ICMR), India

                Melese Abate Reta, University of Pretoria, South Africa

                *Correspondence: Abdulaziz Ibrahim Alzarea, aizarea@ 123456ju.edu.sa ; Tauqeer Hussain Mallhi, thhussain@ 123456ju.edu.sa , tauqeer.hussain.mallhi@ 123456hotmail.com
                Article
                1370344
                10.3389/fphar.2024.1370344
                11186297
                38898922
                5e8380fd-a40c-40a1-8a34-ee3347b8289f
                Copyright © 2024 Alzarea, Saifullah, Khan, Alanazi, Alatawi, Algarni, Almalki, Alahmari, Alhassan and Mallhi.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 17 January 2024
                : 15 April 2024
                Funding
                The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The authors extend their appreciation to the Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia for funding this research work through project number 223202.
                Categories
                Pharmacology
                Original Research
                Custom metadata
                Drugs Outcomes Research and Policies

                Pharmacology & Pharmaceutical medicine
                tuberculosis,resistant-tuberculosis,sputum smear,culture,treatment outcomes,pharmacotherapy

                Comments

                Comment on this article